Trial NCT04863248

View at ClinicalTrials.gov 
Org. Study IDs: G1T28-210
Secondary IDs: 2021-000186-32

Last trial update was posted on 2023-04-14

MeSH Interventions

Docetaxel

MeSH Conditions

Carcinoma, Non-Small-Cell Lung Lung Neoplasms

Other Conditions

Lung Cancer Metastatic Non-Small Cell Lung Cancer NSCLC

Stopping Reasons

Treatment paradigm in second- and third-line NSCLC is shifting away from docetaxel, the backbone chemotherapy therapy used in this study.

Limitations And Caveats

This study was terminated earlier than initially proposed by the Sponsor for non-safety related reasons; only 7 patients were randomized and treated. Therefore, only limited safety summary tables were generated, and no efficacy analyses were conducted.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID